Sarepta’s stock slammed after patient dies of liver failure. Here’s what Wall Street is saying.
The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.
U.S. News & World Report1y
7 Best Pharmaceutical Stocks to Buy for Income
Argus has a "buy" rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating rheumatoid ...